DNV Comprehensive Stroke CenterCoxHealth is certified as a DNV Comprehensive Stroke Center (CSC). Comprehensive Stroke Centers represent the most advanced stroke treatment available in a geographic area. Show
DNV GL's stroke certification programs incorporate elements from our NIAHO® hospital accreditation standards, as well as requirements from the Guidelines of the Brain Attack Coalition and Recommendations of the American Stroke Association. The emphasis these programs place on deploying a disciplined management system, combined with the relevant clinical best practices, sets DNV GL stroke certifications apart from other programs. GWTG = Get With The Guidelines, STK = stroke measure set, t-PA = tissue plasminogen activator, VTE = venous thromboembolism Get With The Guidelines® (GWTG) is the premier hospital-based quality improvement program for the American Heart Association and the American Stroke Association, empowering health care provider teams to consistently treat stroke patients using current evidence-based guidelines. CoxHealth uses the GWTG aggregate comparative data for internal quality improvement, as well as for comparison to other Comprehensive Stroke Centers throughout the nation. Door-to-Needle ExplanationTarget: Stroke, launched by the American Heart Association/American Stroke Association in 2010, is a national quality improvement initiative focused on improving acute ischemic stroke care by reducing door-to-needle times for eligible patients being treated with tPA. The benefits of tPA in patients with acute ischemic stroke are time-dependent, and guidelines recommend a door-to-needle time of 60 minutes or less. However, studies have found that less than 30 percent of U.S. patients are treated within this window. Target: Stroke goals have been updated in order to continue to focus on door-to-needle times, as well as endovascular therapy door-to-puncture times. Target: Stroke aims to continue to reduce door-to-needle times for eligible patients being treated with tPA by establishing more aggressive goals for participating hospitals. The goals for Target: Stroke are:
Improving door-to-needle times in acute ischemic stroke: the design and rationale for the American Heart Association/American Stroke Association's Target: Stroke initiativeGregg C Fonarow et al. Stroke. 2011 Oct. AbstractBackground and purpose: The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time-dependent, and guidelines recommend a door-to-needle time of ≤60 minutes. However, fewer than one third of acute ischemic stroke patients who receive tPA are treated within guideline-recommended door-to-needle times. This article describes the design and rationale of Target: Stroke, a national initiative organized by the American Heart Association/American Stroke Association in partnership with other organizations to assist hospitals in increasing the proportion of tPA-treated patients who achieve guideline-recommended door-to-needle times. Methods: The initial program goal is to achieve a door-to-needle time≤60 minutes for at least 50% of acute ischemic stroke patients. Key best practice strategies previously associated with achieving faster door-to-needle times in acute ischemic stroke were identified. Results: The 10 key strategies chosen by Target: Stroke include emergency medical service prenotification, activating the stroke team with a single call, rapid acquisition and interpretation of brain imaging, use of specific protocols and tools, premixing tPA, a team-based approach, and rapid data feedback. The program includes many approaches intended to promote hospital participation, implement effective strategies, share best practices, foster collaboration, and achieve stated goals. A detailed program evaluation is also included. In the first year, Target: Stroke has enrolled over 1200 United States hospitals. Target: Stroke, a multidimensional initiative to improve the timeliness of tPA administration, aims to elevate clinical performance in the care of acute ischemic stroke, facilitate the more rapid integration of evidence into clinical practice, and improve outcomes. Similar articles
Cited by
Publication typesMeSH termsSubstancesLinkOut - more resources
What is the doorFaster treatment with intravenous alteplase (tissue-type plasminogen activator) results in better outcomes. Although the benchmark door-to-needle time (DTN) has been set at 60 minutes,2 many centers have been able to exceed this benchmark with median times from 20 to 51 minutes.
What is the door to device time goal for direct arriving patients with acute ischemic?Background and Purpose—
The benefits of intravenous tissue-type plasminogen activator (tPA) in acute ischemic stroke are time-dependent, and guidelines recommend a door-to-needle time of ≤60 minutes.
What is the door to CT time for stroke?Stroke code activations door to CT metric. Goal time for door to CT is 25 minutes. Average time for door to CT is currently 30 minutes. 40% of stroke code activations are within goal time for door to CT metric.
What are the treatment goals during the acute phase of ischemic stroke?After an ischemic stroke, the goal of treatment is to restore blood flow to the affected area of the brain as quickly as possible, that is, within the first hours after the onset of stroke symptoms.
|
What is the door-to-needle time goal FOR 85 or more of acute ischemic stroke patients
zusammenhängende Posts
Urheberrechte © © 2024 de.ketajaman Inc.
